Study Utilizing Rilonacept in Gout Exacerbations - NCT00855920-48221 (Clinical Trial 275858)


Welcome To Clinical Connection



Our clinical trials database is updated daily
Over 250,000 individuals are currently being connected to clinical trials by ClinicalConnection.com!


Trials Alerts	Trials Search
Health Forum	Health News
RSS	Intro
Clinics & Sponsors	Member Login

View Clinical Trial (Medical Research Study)

Study Utilizing Rilonacept in Gout Exacerbations - NCT00855920-48221 (Clinical Trial 275858)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy275858.aspx

** Please review additional "Nearby Studies" on right ----->

City:

Detroit

State:

Zip Code:

48221

Conditions:

Acute Gout Flare

Purpose:

This purpose of this clinical research is to determine the efficacy and safety of an experimental drug called rilonacept in subjects with an acute gout attack. Subjects will participate in in this study for 30 days. Rilonacept alone is being compared with indomethacin alone and the combination of rilonacept plus indomethacin in treating acute gout flares.

Study summary:

Criteria:

Inclusion Criteria: 1. Male or female 18 - 70 years of age 2. Previously met the preliminary criteria of ARA for the classification of the acute arthritis of primary gout 3. Presenting with an acute attack (flare) of gout within 48 hours of pain onset and pain of at least moderate severity 4. Must have at least 1 on the 0-3 scale for the swelling and the tenderness assessments of the gouty index joint 5. Current presentation of acute gout flare in 3 joints or less Exclusion Criteria: 1. Treatment with any NSAIDs or opiates within 48 hours prior to baseline assessments. Treatment with long-acting NSAIDs within 1 month prior to baseline visit. Treatment with naproxen, meloxicam, nabumetone, celecoxib and indomethacin SR within 5 days prior to baseline visit. 2. Treatment with oral analgesics within 6 hours before baseline assessments. Treatment with topical analgesics within 12 hours before baseline assessments 3. History of NSAID intolerance 4. Subjects with history of chronic, gouty arthritis

Study is available at:

Detroit, MI 48221
United States

Primary Contact:
Robert Evans
Email: robert.evans@regeneron.com
Phone: 9143457400

If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.

Trials Alerts:

If you would like to be notified of new clinical trials as they become available please register for a free account.

Data Source:		ClinicalTrials.gov
Date Processed:		March 16, 2010
Modifications to this listing:		Only selected fields are shown, please use the link above to view all information about this clinical trial.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.


Featured Nearby Studies:

Within 25 Miles

Rheumatoid Arthritis - Bingham Farms MI

Psoriasis - Rochester MI

Within 50 Miles

Within 100 Miles


Clinical Trials Search

ClinicalConnection.com is a resource that provides individuals with information regarding clinical trials that are being conducted nationwide.
ClinicalConnection.com does not conduct these clinical trials nor endorse them. Please consult your doctor or physician before participating.